@文章{信息:doi/10.2196/15505，作者=“Del Hoyo, Javier和Nos, Pilar和Bastida, Guillermo和Faubel, Raquel和Mu{\~{n}}oz, Diana和Garrido-Mar{\ \ i}n, Alejandro和Valero-P{\ \ e}rez, Elena和beja - serrano, Sergio和Aguas, Mariam”，标题=“克罗恩病和溃疡性结肠炎(TECCU)的远程监测:成本效益分析”，期刊=“J Med Internet Res”，年=“2019”，月=“9”，日=“13”，卷=“21”，数=“9”，页=“e15505”，关键词=“远程医疗;电子健康;成本效益;炎症性肠病;克罗恩病;背景:虽然电子卫生干预措施被认为是安全有效的，但缺乏关于炎症性肠病远程监测成本效益的证据。目的:我们的目的是评估的成本效益和成本效用Telemonitorizaci {\ ' o} n y de la患有德克罗恩病结肠炎Ulcerosa(遥控克罗恩病和溃疡性结肠炎[TECCU])网络平台(G {\ _} TECCU干预组)对于远程控制复杂的炎症性肠病,相比之下,标准治疗(G{\ _}控制)和手术室协助电话护理(G {\ _} NT干预组)。方法:我们从社会角度分析成本-效果，通过比较之前在西班牙某三级大学医院进行的一项24周随机对照试验中使用的3种随访方法。连续招募使用免疫抑制剂或生物制剂，或两者兼而有之的炎症性肠病患者来控制炎症活性。收集了对疾病活动性(使用临床指标)和质量调整生命年(使用EuroQol 5维度问卷)影响的数据。 We calculated the costs of health care, equipment, and patients' productivity and social activity impairment. We compared the mean costs per patient, utilities, and bootstrapped differences. Results: We included 63 patients (21 patients per group). TECCU saved {\texteuro}1005 (US {\$}1100) per additional patient in remission compared with G{\_}control (95{\%} CI {\texteuro}--13,518 to 3137; US {\$}--14,798 to 3434), with a 79.96{\%} probability of being more effective at lower costs. Compared with G{\_}NT, TECCU saved {\texteuro}2250 (US {\$}2463) per additional patient in remission (95{\%} CI {\texteuro}--15,363 to 11,086; US {\$}--16,817 to 12,135), and G{\_}NT saved {\texteuro}538 (US {\$}589) compared with G{\_}control (95{\%} CI {\texteuro}--6475 to 5303; US {\$}--7088 to 5805). G{\_}TECCU and G{\_}NT showed an 84{\%} and 67{\%} probability, respectively, of producing a cost saving per additional quality-adjusted life-year (QALY) compared with G{\_}control, considering those simulations that involved negative incremental QALYs as well. Conclusions: There is a high probability that the TECCU Web platform is more cost-effective than standard and telephone care in the short term. Further research considering larger cohorts and longer time horizons is required. Trial Registration: ClinicalTrials.gov NCT02943538; https://clinicaltrials.gov/ct2/show/NCT02943538 (http://www. webcitation.org/746CRRtDN) ", issn="1438-8871", doi="10.2196/15505", url="//www.mybigtv.com/2019/9/e15505/", url="https://doi.org/10.2196/15505", url="http://www.ncbi.nlm.nih.gov/pubmed/31538948" }